Zoetis Inc. (ZTS) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Drug Manufacturers - Specialty & Generic
Zoetis Inc. (ZTS) Profile & Business Summary
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Key Information
| Ticker | ZTS |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.zoetis.com |
Market Trend Overview for ZTS
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-08-17 (ET)
As of 2026-08-17, ZTS is moving sideways with low volatility. Over the longer term, the trend remains bearish.
ZTS last closed at 72.97. The price is about 1.0 ATR below its recent average price (75.98), and the market is currently in a sideways market with low volatility. Price at 72.97 is moving between light support near 72.38 and light resistance near 76.99. Direction remains unclear. View Support & Resistance from Options
Price is moving in a tight range. This often leads to a stronger move once the range breaks, increasing one-sided risk.
Trend score: 40 out of 100. Overall alignment is unclear. The market is currently in a sideways phase with tightening price movement. The longer-term trend is still negative, but short-term signals are not yet confirming it.
There is no clear key risk boundary right now.
On 2026-04-30, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-07-22] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Buying into the close appeared steady and controlled, consistent with deliberate overnight positioning.
The model sees a bearish edge, but still treats it as a selective downside setup rather than an aggressive downside call.
Up probability is only 36.9%, with predictability at 63% and agreement at 93%. Reversal risk is 14%, while reward/risk stands at -0.28. That suggests downside pressure is present, while the setup still remains selective rather than extreme. At the same time, recent price behavior has shown failed reversal memory.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 18 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-08-17. The current price is 72.97, 2.43% below the estimated average cost of 74.79. An estimated 26.1% of recent positioning is below the current price, while 73.5% is above it. The peak-density price is 72.58. The largest concentrated cost region is 73.79 to 76.11 and contains 40.7% of the estimated distribution. The current price is within the 72.97 to 72.99 cost region. The nearest region below the current price is 72.31 to 72.77. The nearest region above the current price is 73.03 to 73.09.
Short Interest & Covering Risk for ZTS
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is relatively low, indicating limited pressure from short positions. (Historical percentile: 22%)
Structure Analysis
ZTS Short positioning looks normal. Current days to cover is 3.9 trading days, meaning short positions would unwind somewhat slower than average. Short covering is likely to have a normal impact on price moves. Early signs of positioning pressure are emerging (Fragility Score 42/100, DTC percentile 79%) with short positioning continuing to expand and liquidity contracting meaningfully (volume -28%).
Risk Summary
Some early warning signs are emerging. Price strength remains intact, but underlying support may be starting to weaken.This indicator is intended as a risk filter, not a directional signal. A High or Extreme reading does not predict an immediate move, but suggests that if prices weaken, downside reactions may be more pronounced.
Why Price Reactions May Be Stronger?
Days-to-Cover is elevated versus its own history, but absolute short interest remains moderate. In the latest reporting period, short interest continues to increase. Average trading volume is weakening, indicating contracting liquidity. Phase: Building. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. Rising short pressure is occurring while liquidity is deteriorating. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-07-31 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.